Theravance Biopharma Stock Forecast

Buy or Hold candidate since Jun 16, 2026 Gain 1.02%

The Theravance Biopharma stock price gained 0.0593% on the last trading day (Friday, 31st Jul 2026), rising from $16.85 to $16.86. During the last trading day the stock fluctuated 0.178% from a day low at $16.85 to a day high of $16.88. The price has risen in 4 of the last 10 days but is still down by -0.41% for this period. Volume fell on the last day by -34 thousand shares and in total, 347 thousand shares were bought and sold for approximately $5.85 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 3.47% during the next 3 months and, with a 90% probability hold a price between $16.54 and $18.49 at the end of this 3-month period.

TBPH Signals & Forecast

Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Theravance Biopharma stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $16.86 and $16.89. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, June 26, 2026, and so far it has fallen -4.37%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Theravance Biopharma stock

Theravance Biopharma finds support from accumulated volume at $16.81 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.0300 between high and low, or 0.178%. For the last week the stock has had daily average volatility of 0.243%.

Our recommended stop-loss: $16.19 (-3.95%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 24 days ago.)

Trading Expectations (TBPH) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Theravance Biopharma to open at $16.86, and during the day (based on 14 day Average True Range), to move between $16.79 and $16.93, which gives a possible trading interval of +/-$0.141 (+/-0.84%) up or down from last closing price. If Theravance Biopharma takes out the full calculated possible swing range there will be an estimated 0.84% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $16.81 (0.30%) than the resistance at $16.93 (0.42%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Theravance Biopharma stock A Buy?

Theravance Biopharma holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.421 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $16.86 ( 0.0198%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk